Evidence mapPaperPMID 41290905Full record

ArticleScientific reports2025

Global, regional, and national burden of ischemic heart disease in young and middle-aged population from 1990 to 2021.

Jiayi Song, Kun Yuan, Yilin Huang, Zuo Chen, Xin Wang, Zengwu Wang, Linfeng Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiayi Song *Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Kun Yuan *Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Yilin Huang *Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Zuo ChenDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Xin WangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Zengwu WangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China.
Linfeng ZhangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 15 (Lin), Fengcunxili, Mentougou District, Beijing, 102308, China. zlfnccd@sina.com.cn.

Funding

National Natural Science Foundation of China 81973117
6 · The paper itself

Abstract

Early-onset ischemic heart disease (IHD) is an emerging global health concern. Quantifying its burden and key risk factors is essential for effective prevention and control. This study utilizes the data from Global Burden of Disease Study 2021 to analyze the burden of IHD in young and middle-aged population (15-49 years old), including prevalence, incidence, deaths and disability-adjusted life years (DALYs) from 1990 to 2021. Attributable risk factors were assessed across different sex and region, and trends were analyzed using age-standardized rate (ASR) and average annual percentage change (AAPC). In 2021, the ASR of prevalence and incidence showed an increasing trend, with AAPCs of 0.26% (95% confidence interval [CI], 0.24% to 0.29%) and 0.23% (95%CI, 0.09% to 0.38%), respectively; the ASR of mortality and DALYs showed a decreasing trend, with AAPCs of -0.67 (95%CI, -0.91% to -0.44%) and - 0.64 (95%CI, -0.87% to -0.42%).The highest burden were observed in countries with low-middle socio-demographic index. Gender differences were observed, with men generally bearing a higher burden. Dietary risks were identified as the most significant risk factors. The burden of early-onset IHD remains a major health challenge, with significant region and gender disparities. The burden needs to be addressed through targeted public health policies.

Indexed as

Myocardial IschemiaAdolescentAdultCost of IllnessDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseGlobal HealthHumansIncidenceMaleMiddle AgedPrevalenceQuality-Adjusted Life YearsRisk FactorsYoung AdultEarly onset of diseaseGlobal burden of diseaseIschemic heart diseaseRisk factorsYoung and middle-aged population

Identifiers

PMID41290905
PMCPMC12647134

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.